Last updated: September 23, 2024
Sponsor: Groupe Hospitalier Sud Ile-de-France
Overall Status: Active - Recruiting
Phase
N/A
Condition
Kidney Disease
Kidney Failure
Renal Failure
Treatment
Sustained Low-Efficiency Dialysis
Clinical Study ID
NCT04968587
2020-A0122-37
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- All patient requiring Renal replacement Therapy
Exclusion
Exclusion Criteria:
Age < 18 years
Pregnancy
Hypercalcemia ≥ 3 mmol/L.
Major under guardianship
Major deprived of freedom
Impossible to obtain free and informed consent
Presence of hemostasis or coagulation disorders:
Thrombocytopenia < 30 G/L.
Curative anticoagulation.
Severe liver disease with Prothrombin rate <30%.
Coagulation factor deficit.
Not registered to a social security system.
Study Design
Total Participants: 138
Treatment Group(s): 1
Primary Treatment: Sustained Low-Efficiency Dialysis
Phase:
Study Start date:
February 01, 2022
Estimated Completion Date:
November 01, 2025
Study Description
Connect with a study center
Groupe Hospitalier Sud Ile-de-France
Melun, 77000
FranceActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.